Navigation Links
Critical step traced in anthrax infection

Scientists at Harvard Medical School (HMS) have revealed details of a key step in the entry of anthrax toxin into human cells. The work, which grew out of an ongoing effort to produce a better anthrax therapeutic, shows that the protective antigen component of the bacterial toxin plays an active role in transferring the other two components of the toxin through the cell membrane.

The research, led by R. John Collier, professor of microbiology and molecular genetics at HMS, provides insight into the broader question of how proteins cross cell membranes. The findings appear in the July 29 issue of Science.

An anthrax bacterium secretes three nontoxic proteins that assemble into a toxic complex on the surface of the host cell to set off a chain of events leading to cell toxicity and death. Protective antigen (PA) is one of these proteins, and after binding to the cell, seven copies of it assemble into a specific complex that is capable of forming a pore in a cellular membrane. The pore permits the other two proteins, lethal factor (LF) and edema factor (EF), to enter the cell interior, where the factors interfere with metabolic processes, leading to death of the infected individual.

Details surrounding this process are continuing to be uncovered in Collier's lab. "Until now, we have not known whether the PA pore serves simply as a passive conduit, or alternatively, plays an active role in shepherding the unfolded LF and EF molecules through," he said. The findings show that it is the latter?the pore takes an active role in protein translocation.

The scientists demonstrated this role by investigating the channel's chemical make-up. Using a procedure known as cysteine-scanning mutagenesis, they identified the hydrophobic, or "greasy," amino acid phenylalanine in protective antigen's pore-forming domain. Seven of these amino acids project into the lumen of the pore and form a collection of greasy residues, nicknamed "the phi-clamp" by the sc
'"/>

Source:Harvard Medical School


Page: 1 2

Related biology news :

1. Critical role in programmed cell death identified
2. White Blood Cell Waste Disposal System Plays Critical Regulatory Role
3. Critical hearing gene helps send auditory messages to brain
4. Scientists seek answers on what activates deadly anthrax spores
5. Antibodies from plants protect against anthrax
6. Defensins neutralize anthrax toxin
7. US Army plans to bulk-buy anthrax
8. New antibody shows promise as cure for anthrax
9. Effective, safe anthrax vaccine can be grown in tobacco plants
10. UCSD study finds anthrax toxins also harmful to fruit flies
11. Driver of anthrax toxicity could lead to late-stage therapy
Post Your Comments:
(Date:5/15/2008)...en Staehling-Hampton, Ph.D., Managing Director of ...estigator, collaborated with colleagues from aroun...al mutations in chick and mouse model systems also...genital vertebral abnormalities. , The discover...can Journal of Human Genetics. , Working with s...
(Date:5/15/2008)... and his celebrated brother will each receive hono...emony. Last year each brother was named in the Que...iversity of Nottingham Research Professor in Chemi...he acclaimed playwright and director Stephen Polia...eir remarkable contribution to British science and...
(Date:5/14/2008)...nd biological systems across the earth are being a...says a new analysis of information not previously ...hings include earlier leafing of trees and plants ...latitudes and altitudes in the northern hemisphere...ica and Australia; and shifting of the oceans plan...
(Date:5/14/2008)...ere once widespread in the Pacific Northwests west...e suppression, conifer and invasive plant encroach...s of as much as 99 percent of the oak communities ..., A new technical report titled "Evaluation of L...t Prairie, Washington" outlines the findings of a ...
Breaking Biology News(10 mins):Stowers Institute researchers identify gene linked to vertebral defects in patient populations 2Boffinry and Baftas: Brothers' double doctorates 2Warming climate is changing life on global scale, says new study 2Eclipsys Sunrise Acute Care Receives CCHIT Certification 5526 1Eclipsys Sunrise Acute Care Receives CCHIT Certification 5526 2Eclipsys Sunrise Acute Care Receives CCHIT Certification 5526 3Eclipsys Sunrise Acute Care Receives CCHIT Certification 5526 4New Survey Finds One in Four Baby Boomers Erroneously Believe They Have Coverage for Long Term Care Expenses 5523 1New Survey Finds One in Four Baby Boomers Erroneously Believe They Have Coverage for Long Term Care Expenses 5523 2New Survey Finds One in Four Baby Boomers Erroneously Believe They Have Coverage for Long Term Care Expenses 5523 3HGS unveils positive QOL results from Phase 2B trial of Albuferon for hepatits C 5520 1HGS unveils positive QOL results from Phase 2B trial of Albuferon for hepatits C 5520 2HGS unveils positive QOL results from Phase 2B trial of Albuferon for hepatits C 5520 3John Vercoe Conference 1105 1John Vercoe Conference 1105 2
...ning infection in the body, a virus such as HIV in... the cell,s outer membrane. Once inside the cell, ..., turning the ,host, cell into a factory to produc...o invade other cells in the body. , Scientists had...ll,s membrane, infection of the host cell was inev...
...the impact of malaria is in prospect with a clinic...ext year. Success in the trial would open the way ...s debilitating and often fatal disease - over 500,...tute of Medical Research is collaborating with the...NGIMR) and the University of Melbourne to confirm ...
...rancisco VA Medical Center (SFVAMC) and the Univer...tified six genes associated with lymphocytic bronc...onchitis (OB), the most common cause of long-term ...ope their results will lead to an earlier, more se...ic lung rejection, as well as greater understandin...
...rida panthers has grown from a previously estimate...troversial breeding effort to improve the genetic ...ding to a new assessment. , Hybrid kittens born to...bout a three times higher chance of becoming adult...r publication in January 2006 in the British journ...
Other Biology News:Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 2Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 3Old drug, new tricks: Prospects for slashing the impact of malaria 2Researchers identify genes associated with lung transplant rejection 2Research suggests fitness of Florida panthers improved by limited breeding with Texas animals 2Research suggests fitness of Florida panthers improved by limited breeding with Texas animals 3
(Date:5/16/2008)...rstCall/ -- Highlighting the,company,s expectation...peline, Michael V. Novinski, President and CEO of ... featured in an extensive interview published,rece...shed more than 40,years ago, TWST interviews the l...sts and money managers, and publishes their viewpo...
(Date:5/16/2008)...erapeutics Corporation,announced today that it has...elve-week Phase IIb trial with oral larazotide ace...on, for the treatment of patients with active,celi...ed, double-blind,placebo-controlled study will ev...ety and tolerability of larazotide acetate in 106 ...
(Date:5/16/2008)...-FirstCall/ -- MAP,Pharmaceuticals, Inc. (Nasdaq: ...ent at the 2008 Citi Investment Research Global He... 9:00 am (ET) in New York City., A live webcast o...or,Relations section of MAP Pharmaceuticals, websi...so be available within 24 hours,for seven days fol...
(Date:5/16/2008)...-- Stereotaxis, Inc. (Nasdaq:,STXS), announced tod...ll,present at the Seventh Annual JMP Securities Re... 20, 2008 at 12:00 p.m. Pacific Time., Attendance...o,presentation will be webcast live and remain ava...jmp6/stxs/ ., About Stereotaxis, Stereotaxis des...
Breaking Biology Technology:Michael V. Novinski, Emisphere President/CEO Featured in the Wall Street Transcript 2Michael V. Novinski, Emisphere President/CEO Featured in the Wall Street Transcript 3Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 2Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 3
...ng the significant rise in valuation of Genentech...ue product innovation through focused R&D efforts ...onfidence and resulting market valuation. , ,While...ts market value last week hit $74.2 billion. , ,Th..., is pretty close to Merck,s $75 billion and is ju...
The British are interested in bio and life science investments in the United States and they,re looking at Wisconsin. Meanwhile the University of Wisconsin-Madison is introducing two new interdiscip
...d its MailFoundry line of anti-spam hardware, re...x on OEM hardware instead of using a Sun platform,...t three times as fast as the MailFoundry 1100, acc...ct processor speeds are not yet available. And the...the hardware, Solinus provides subscription-based ...
... summaries of their businesses for angel investors... , ,The Wisconsin Angel Network will launch a se...ith entrepreneurs based on the investors, market i...d a deal-flow pipeline, has been designed to be a ...angels more efficiently than conferences or contes...
Other Biology Technology:Drug innovation beats marketing, patents and mergers 2Start-ups, angels can connect on new state Web site 2Start-ups, angels can connect on new state Web site 3
MAb to IgG2 (Fc gamma-2) IgG2 (Fc, gamma-2 epitope)
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z37,208-0) or contact custom
Gel Loading Buffer contains a precipitant to ensure that the samples sink into the wells and a tracking dye to allow the user to follow the progress of electrophoresis.
Gel loading solution, Type I is formulated for non-denaturing polyacrylamide and agarose gel electrophoresis of nucleic acids and offers the advantage of two tracking dyes (bromphenol blue and xylene
Biology Products: